TP53 and breast neoplasm: According to our hypothesis, and considering that in multivariate analysis the nuclear colocalization of p53 and p65, but not of each transcription factor alone, retained its prognostic value, our results strongly suggest that p53 mutant breast tumors are more likely to relapse earlier to chemotherapy because of the ability to activate NF-κB target genes.